Name: Innovation versus Financialization in the US Pharmaceutical Industry
SKU: 64763045
Price: 36.09 USD
Availability: InStock
Author: Oner Tulum;William Lazonick

Selecciona tu país

América

Europa

Resto del mundo

portada Innovation versus Financialization in the US Pharmaceutical Industry

Innovation versus Financialization in the US Pharmaceutical Industry

Formato

Libro Físico

Editorial

Cambridge University Press

Autor

Oner Tulum;William Lazonick

Colección

Elements in Corporate Governance

Año

2025

N° páginas

Encuadernación

Tapa Blanda

ISBN13

9781009707985

Innovation versus Financialization in the US Pharmaceutical Industry

Oner Tulum;William Lazonick (Autor) · Cambridge University Press · Tapa Blanda

Libro Nuevo Importado

Envío: 16 a 22 días háb.

$ 72.19$ 36.09

-50%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 50 unidades

$ 36.09

Llega entre el 22 Sep y el 02 Oct a Quito, Pichincha. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Innovation versus Financialization in the US Pharmaceutical Industry"

The US government is negotiating with pharmaceutical companies on the price of ten drugs. This Element shows that the companies (a) should have their drug prices regulated, (b) use their profits to distribute cash dividends and stock buybacks; (c) do not rely on investment by shareholders; and (d) benefit from 'collective and cumulative learning.'